Olshan Secures Board Representation and Corporate Governance Enhancements at Vaxart for Stockholder Group

Olshan represented a group of retail stockholders in their campaign at Vaxart that culminated with an agreement pursuant to which a mutually agreed director will be appointed to Vaxart’s board of directors. Vaxart also agreed to form Stockholder Engagement and Clinical and Regulatory Affairs Committees, refresh the committees of the board, including by selecting new chairs for the Nominating and Governance and Compensation Committees, and adopt director stock ownership and resignation policies. Vice Chair of Olshan’s Shareholder Activism Practice Group Ryan Nebel and Joseph Ferrone represented the stockholder group in connection with its campaign at Vaxart.